AS WARRANT AGENTPreferred Stock Warrant Agreement • May 20th, 2021 • Aclaris Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 20th, 2021 Company Industry JurisdictionTHIS PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [·], between ACLARIS THERAPEUTICS, INC., a Delaware corporation (the “Company”), and [·], a [corporation] [national banking association] organized and existing under the laws of [·] and having a corporate trust office in [·], as warrant agent (the “Warrant Agent”).
AS WARRANT AGENTCommon Stock Warrant Agreement • May 20th, 2021 • Aclaris Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 20th, 2021 Company Industry JurisdictionTHIS COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [·], between ACLARIS THERAPEUTICS, INC., a Delaware corporation (the “Company”), and [·], a [corporation] [national banking association] organized and existing under the laws of [·] and having a corporate trust office in [·], as warrant agent (the “Warrant Agent”).
AS WARRANT AGENTDebt Securities Warrant Agreement • May 20th, 2021 • Aclaris Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 20th, 2021 Company Industry JurisdictionTHIS DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of [·], between ACLARIS THERAPEUTICS, INC., a Delaware corporation (the “Company”), and [·], a [corporation] [national banking association] organized and existing under the laws of [·] and having a corporate trust office in [·], as warrant agent (the “Warrant Agent”).